Publications for Gopala Rangan
2016
cells. BMC Nephrology, 16(1), 1-13. <a
href="http://dx.doi.org/10.1186/s12882-015-019
3-3">[More Information]</a>
Chua, T., Prasad, N., Rangan, G.,
Allman-Farinelli, M., Rangan, A. (2016). A
systematic review to determine the most
effective interventions to increase water intake.
Nephrology, in press. <a
href="http://dx.doi.org/10.1111/nep.12675">[Mo
re Information]</a>
Savige, J., Tunnicliffe, D., Rangan, G. (2015).
KHA-CARI Autosomal Dominant Kidney
Disease Guideline: Management of Chronic
Pain. Seminars in Nephrology, 35(6),
607-611.e3. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.013">[More Information]</a>
Rangan, G. (2016). C5b-9 does not mediate
tubulointerstitial injury in experimental acute
glomerular disease characterized by selective
proteinuria. World Journal of Nephrology, 5(3),
288-299. <a
href="http://dx.doi.org/10.5527/wjn.v5.i3.288">[
More Information]</a>
Campbell, K., Rangan, G., Lopez-Vargas, P.,
Tong, A. (2015). KHA-CARI Autosomal
Dominant Polycystic Kidney Disease Guideline:
Diet and Lifestyle Management. Seminars in
Nephrology, 35(6), 572-581.e17. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.008">[More Information]</a>
Tong, A., Tunnicliffe, D., Lopez-Vargas, P.,
Mallett, A., Patel, C., Savige, J., Campbell, K.,
Patel, M., Tchan, M., Alexander, S., Lee, V.,
Craig, J., Rangan, G., et al (2016). Identifying
and integrating consumer perspectives in clinical
practice guidelines on autosomal-dominant
polycystic kidney disease. Nephrology, 21(2),
122-132. <a
href="http://dx.doi.org/10.1111/nep.12579">[Mo
re Information]</a>
Tchan, M., Savige, J., Patel, C., Mallett, A.,
Tong, A., Tunnicliffe, D., Rangan, G. (2015).
KHA-CARI Autosomal Dominant Polycystic
Kidney Disease Guideline: Genetic Testing for
Diagnosis. Seminars in Nephrology, 35(6),
545-549.e2. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.007">[More Information]</a>
Publications for Gopala Rangan
2015
Tong, A., Rangan, G., Ruospo, M., Saglimbene,
V., Strippoli, G., Palmer, S., Tunnicliffe, D.,
Craig, J. (2015). A painful inheritance-patient
perspectives on living with polycystic kidney
disease: thematic synthesis of qualitative
research. Nephrology, Dialysis, Transplantation,
30(5), 790-800. <a
href="http://dx.doi.org/10.1093/ndt/gfv010">[M
ore Information]</a>
Alexander, S., Rangan, G., Tchan, M.,
McCarthy, W., Mallett, A., Patel, C., Maier, A.,
McGaughran, J., Gabbett, M., Takasato, M., et al
(2015). A protocol for the identification and
validation of novel genetic causes of kidney
disease. BMC Nephrology, 16(1), 1-10. <a
href="http://dx.doi.org/10.1186/s12882-015-014
8-8">[More Information]</a>
Rangan, G., Lopez-Vargas, P., Nankivell
(Nankievell), B., Tchan, M., Tong, A.,
Tunnicliffe, D., Savige, J. (2015). Autosomal
Dominant Polycystic Kidney Disease: A Path
Forward. Seminars in Nephrology, 35(6),
524-537. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.002">[More Information]</a>
Ta, M., Liuwantara, D., Rangan, G. (2015).
Effects of pyrrolidine dithiocarbamate on
proliferation and nuclear factor-κB activity in
autosomal dominant polycystic kidney disease
Patel, C., Tchan, M., Savige, J., Mallett, A.,
Tong, A., Tunnicliffe, D., Rangan, G. (2015).
KHA-CARI Autosomal Dominant Polycystic
Kidney Disease Guideline: Genetics and Genetic
Counseling. Seminars in Nephrology, 35(6),
550-556.e1. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.003">[More Information]</a>
Lee, V., Tunnicliffe, D., Rangan, G. (2015).
KHA-CARI Autosomal Dominant Polycystic
Kidney Disease Guideline: Management of
End-Stage Kidney Disease. Seminars in
Nephrology, 35(6), 595-602.e12. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.011">[More Information]</a>
Lee, V., Dexter, M., Mai, J., Vladica, P.,
Lopez-Vargas, P., Rangan, G. (2015).
KHA-CARI Autosomal Dominant Polycystic
Kidney Disease Guideline: Management of
Intracranial Aneurysms. Seminars in
Nephrology, 35(6), 612-617.e20. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.014">[More Information]</a>
Savige, J., Mallett, A., Tunnicliffe, D., Rangan,
G. (2015). KHA-CARI Autosomal Dominant
Polycystic Kidney Disease Guideline:
Management of Polycystic Liver Disease.
Seminars in Nephrology, 35(6), 618-622.E5. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.015">[More Information]</a>
Mallett, A., Patel, M., Tunnicliffe, D., Rangan,
G. (2015). KHA-CARI Autosomal Dominant
Publications for Gopala Rangan
Polycystic Kidney Disease Guideline:
Management of Renal Stone Disease. Seminars
in Nephrology, 35(6), 603-606 e3. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.012">[More Information]</a>
Mai, J., Lee, V., Lopez-Vargas, P., Vladica, P.,
Rangan, G. (2015). KHA-CARI Autosomal
Dominant Polycystic Kidney Disease Guideline:
Monitoring Disease Progression. Seminars in
Nephrology, 35(6), 565-571.e18. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.005">[More Information]</a>
Mallett, A., Lee, V., Mai, J., Lopez-Vargas, P.,
Rangan, G. (2015). KHA-CARI Autosomal
Dominant Polycystic Kidney Disease Guideline:
Pharmacological Management. Seminars in
Nephrology, 35(6), 582-589.e17. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.009">[More Information]</a>
Tong, A., Mallett, A., Lopez-Vargas, P., Rangan,
G. (2015). KHA-CARI Autosomal Dominant
Polycystic Kidney Disease Guideline:
Psychosocial Care. Seminars in Nephrology,
35(6), 590-594.e5. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.010">[More Information]</a>
Rangan, G., Lee, V., Alexander, S., Patel, C.,
Tunnicliffe, D., Vladica, P. (2015). KHA-CARI
Autosomal Dominant Polycystic Kidney Disease
Guideline: Screening for Polycystic Kidney
Disease. Seminars in Nephrology, 35(6),
557-564.e6. <a
href="http://dx.doi.org/10.1016/j.semnephrol.201
5.10.004">[More Information]</a>
Crawford, S., Chen, S., Halliday, C., Rangan, G.,
Gottlieb, T., Reid, A. (2015). Microsphaeropsis
arundinis skin and soft tissue infection in renal
transplant recipients: three case reports and a
review of the literature. Transplant Infectious
Disease (Print), 17(6), 915-920. <a
href="http://dx.doi.org/10.1111/tid.12464">[Mor
e Information]</a>
2014
Bose, B., Badve, S., Hiremath, S., Boudville, N.,
Brown, F., Cass, A., de Zoysa, J., Fassett, R.,
Faull, R., Harris, D., Perkovic, V., Rangan, G., et
al (2014). Effects of uric acid-lowering therapy
on renal outcomes: a systematic review and
meta-analysis. Nephrology, Dialysis,
Transplantation, 29(2), 406-413. <a
href="http://dx.doi.org/10.1093/ndt/gft378">[Mo
re Information]</a>
Succar, L., Lai-Kwon, J., Nikolic-Paterson, D.,
Rangan, G. (2014). Induction monotherapy with
sirolimus has selected beneficial effects on
glomerular and tubulointersititial injury in
nephrotoxic serum nephritis. International
Journal of Nephrology and Renovascular
Disease, 7, 303-313. <a
href="http://dx.doi.org/10.2147/IJNRD.S64202"
>[More Information]</a>
Chaudhry, R., Rangan, G. (2014). Levels of
haloacetic acids in tap water in an urban
Australian city and its relevance to autosomal
dominant polycystic kidney disease. Kidney
International, 85(6), 1471-1471. <a
href="http://dx.doi.org/10.1038/ki.2014.97">[M
ore Information]</a>
Rangan, G., Nankivell (Nankievell), B. (2014).
Management of autosomal dominant polycystic
kidney disease. Medicine Today, 15(6), 16-27.
McDonald, S., Rangan, G. (2014). Polycystic
kidney disease: Progression of polycystic kidney
disease-a lack of progress? Nature Reviews
Nephrology, 10(9), 489-491. <a
href="http://dx.doi.org/10.1038/nrneph.2014.138
">[More Information]</a>
Ta, M., Rao, P., Korgaonkar, M., Foster, S.,
Peduto, A., Harris, D., Rangan, G. (2014).
Pyrrolidine dithiocarbamate reduces the
progression of total kidney volume and cyst
enlargement in experimental polycystic kidney
disease. Physiological Reports, 2(12), 1-15. <a
href="http://dx.doi.org/10.14814/phy2.12196">[
More Information]</a>
Myint, T., Rangan, G., Webster, A. (2014).
Treatments to slow progression of autosomal
dominant polycystic kidney disease: systematic
review and meta -analysis of randomized trials.
Nephrology, 19(4), 217-226. <a
href="http://dx.doi.org/10.1111/nep.12211">[Mo
re Information]</a>
2013
Chapman, J., Rangan, G. (2013). Are
Nonesterified Fatty Acids Protective in Chronic
Allograft Nephropathy? Transplantation, 95(11),
1313-1314. <a
href="http://dx.doi.org/10.1097/TP.0b013e31828
b8fc6">[More Information]</a>
Rangan, G., Schwensen, K., Foster, S.,
Korgaonkar, M., Peduto, A., Harris, D. (2013).
Chronic effects of dietary Vitamin D deficiency
without increased calcium supplementation on
the progression of experimental polycystic
kidney disease. American Journal of Physiology:
Renal Physiology, 305(4), F574-F582. <a
href="http://dx.doi.org/10.1152/ajprenal.00411.2
012">[More Information]</a>
Ta, M., Rao, P., Korgaonkar, M., Foster, S.,
Peduto, A., Harris, D., Rangan, G. (2013).
Pyrrolidine Dithiocarbamate Attenuates Kidney
Enlargement in Experimental Polycystic Kidney
Disease. Nephrology, 18(Supp. 1), 37-37.
Publications for Gopala Rangan
Rangan, G., Harris, D. (2013). Rationale and
Design of an Observational Study to Determine
the Effects of Cholecalciferol on Hypertension,
Proteinuria and Urinary MCP-1 in ADPKD.
Current Hypertension Reviews, 9(2), 115-120. <a
href="http://dx.doi.org/10.2174/1573402111309
9990006">[More Information]</a>
Ta, M., Harris, D., Rangan, G. (2013). Role of
interstitial inflammation in the pathogenesis of
polycystic kidney disease. Nephrology, 18(5),
317-330. <a
href="http://dx.doi.org/10.1111/nep.12045">[Mo
re Information]</a>
2012
Sud, K., Rangan, G. (2012). Peritonitis and
Exit-Site Infections. In David Harris, Grahame
Elder, Lukas Kairaitis, Gopala Rangan (Eds.),
Pocket Guide to Clinical Dialysis, (pp. 245-255).
Sydney, Australia: McGraw Hill.
Harris, D., Elder, G., Kairaitis, L., Rangan, G.
(2012). Pocket Guide to Clinical Dialysis.
Sydney, Australia: McGraw Hill.
2011
Badve, S., Brown, F., Hawley, C., Johnson, D.,
Kanellis, J., Rangan, G., Perkovic, V. (2011).
Challenges of conducting a trial of
uric-acid-lowering therapy in CKD. Nature
Reviews Nephrology, 7(5), 295-300. <a
href="http://dx.doi.org/10.1038/nrneph.2010.186
">[More Information]</a>
Schwensen, K., Burgess, J., Graf, N., Alexander,
S., Harris, D., Phillips, J., Rangan, G. (2011).
Early Cyst Growth Is Associated with the
Increased Nuclear Expression of Cyclin D1/Rb
Protein in an Autosomal-Recessive Polycystic
Kidney Disease Rat Model. Nephron
Experimental Nephrology, 117(4), e93-e103. <a
href="http://dx.doi.org/10.1159/000320149">[M
ore Information]</a>
Succar, L., Harris, D., Rangan, G. (2011). Role
of the Mammalian Target of Rapamycin (mTOR)
Signalling Pathway in Podocytes in Glomerular
Disease. In Sharma S. Prabhakar (Eds.), An
Update on Glomerulopathies - Etiology and
Pathogenesis, (pp. 183-202). Rijeka, Croatia:
InTech Publishers.
2010
Foster, S., Korgaonkar, M., Rangan, G.,
Schwensen, K., Peduto, A. (2010). Changes in
kidney volume in experimental Polycystic
Kidney Disease (PKD) quantified by a clinical
Rangan, G., Burgess, J., Schwensen, K., Harris,
D. (2010). Polycystic kidney disease - Part 2.
Medical Observer, 26 March, 29-31.
Schwensen, K., Foster, S., Korgaonkar, M.,
Peduto, A., Harris, D., Rangan, G. (2010).
Sequential assessment of total kidney volume
(TKV) in experimental autosomal recessive
Polycystic Kidney Disease (ARPKD) using a
clinical 3T scanner. <i>46th Annual Scientific
Meeting of
the Australian and New Zealand Society of
Nephrology</i>.
Schwensen, K., Foster, S., Korgaonkar, M.,
Peduto, A., Harris, D., Rangan, G. (2010).
Sirolimus (S) reduces kidney enlargement but
does not improve cystic microarchitecture in
established Polycystic Kidney Disease (PKD).
<i>46th Annual Scientific Meeting of
the Australian and New Zealand Society of
Nephrology</i>.
2009
Zheng, G., Lyons, J., Tan, T., Wang, Y., Hsu, T.,
Min, D., Succar, L., Rangan, G., Hu, M.,
Henderson, B., Alexander, S., Harris, D. (2009).
Disruption of E-Cadherin by Matrix
Metalloproteinase Directly Mediates
Epithelial-Mesenchymal Transition Downstream
of Transforming Growth Factor-beta1 in Renal
Tubular Epithelial Cells. The American Journal
of Pathology, 175(2), 580-591. <a
href="http://dx.doi.org/10.2353/ajpath.2009.0809
83">[More Information]</a>
Rangan, G., Wang, Y., Harris, D. (2009).
NF-kappaB signalling in chronic kidney disease.
Frontiers in Bioscience, 14, 3496-3522. <a
href="http://dx.doi.org/10.2735/3467">[More
Information]</a>
Rangan, G., Nguyen, T., Mainra, R., Succar, L.,
Schwensen, K., Burgess, J., Ho, K. (2009).
Therapeutic role of sirolimus in non-transplant
kidney disease. Pharmacology and Therapeutics,
123(2), 187-206. <a
href="http://dx.doi.org/10.1016/j.pharmthera.200
9.03.014">[More Information]</a>
2008
Rangan, G. (2008). Haematuria. In David
Harris (Eds.), Clinical Cases in Kidney Disease,
(pp. 63-75). Australia: McGraw Hill.
3T MR Scanner. ISMRM/SMRT Annual Meeting.
Rangan, G., Succar, L. (2008). Rapidly
Progressive Glomerulonephritis. In David
Harris (Eds.), Clinical Cases in Kidney Disease,
(pp. 192-204). Australia: McGraw Hill.
Rangan, G., Burgess, J., Schwensen, K., Harris,
D. (2010). Polycystic kidney disease - Part 1.
Medical Observer, 19 March, 27-29.
Rangan, G. (2008). Renal Mass. In David
Harris (Eds.), Clinical Cases in Kidney Disease,
(pp. 49-62). Australia: McGraw Hill.
Publications for Gopala Rangan
2007
Rangan, G., Tesch, G. (2007). Quantification of
renal pathology by image analysis (Methods in
Renal Research). Nephrology, 12(6), 553-558. <a
href="http://dx.doi.org/10.1111/j.1440-1797.200
7.00855.x">[More Information]</a>
Rangan, G., Coombes, J. (2007). Renoprotective
effects of sirolimus in non-immune initiated
focal segmental glomerulosclerosis. Nephrology,
Dialysis, Transplantation, 22(8), 2175-2182. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17550925">[More Information]</a>
Phillips, J., Hopwood, D., Loxley, R., Ghatora,
K., Coombes, J., Tan, Y., Harrison, J.,
McKitrick, D., Holobotvskyy, V., Arnolda, L.,
Rangan, G. (2007). Temporal relationship
between renal cyst development, hypertension
and cardiac hypertrophy in a new rat model of
autosomal recessive polycystic kidney disease.
Kidney and Blood Pressure Research, 30(3),
129-144.
2006
Lee, V., Wang, Y., Qin, X., Wang, Y., Zheng,
G., Mahajan, D., Coombes, J., Rangan, G.,
Alexander, S., Harris, D. (2006). Adriamycin
nephropathy in severe combined
immunodeficient (SCID) mice. Nephrology,
Dialysis, Transplantation. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16891644">[More Information]</a>
Rangan, G., Kan, G., Steer, J., Dogra, G., Croft,
K., Rhodes, H., Woodroffe, A., Joyce, D. (2006).
Altered expression of nuclear factor-kappa B in
peripheral blood mononuclear cells in chronic
haemodialysis patients. Nephrology, Dialysis,
Transplantation, 21(4), 1137-1139.
Zheng, G., Wang, Y., XIANG, S., Tay, Y., Wu,
H., Watson, D., Coombes, J., Rangan, G.,
Alexander, S., Harris, D. (2006). DNA
vaccination with CCL2 DNA modified by the
addition of an adjuvant epitope protects against
"nonimmune" toxic renal injury. Journal of the
American Society of Nephrology, 17(2), 465-474.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16396966">[More Information]</a>
Zhu, G., Wang, Y., Wang, J., Tay, Y., Yung, T.,
Rangan, G., Harris, D. (2006). Significance of
CD25 positive cells and macrophages in
noncrescentic IgA nephropathy. Renal Failure,
28(3), 229-235. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16703795">[More Information]</a>
Rangan, G. (2006). Sirolimus-associated
proteinuria and renal dysfunction. Drug Safety,
29(12), 1153-1161. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17147461">[More Information]</a>
2005
Geevasinga, N., Kairaitis, L., Rangan, G.,
Coleman, P. (2005). Acute interstitial nephritis
secondary to esomeprazole. Medical Journal of
Australia, 182(5). <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15748135">[More Information]</a>
Rangan, G., Kan, G., Steer, J., Dogra, G., Croft,
K., Rhodes, H., Woodroffe, A., Joyce, D. (2005).
Altered expression of nuclear factor-kappaB in
peripheral blood mononuclear cells in chronic
haemodialysis patients. Nephrology, Dialysis,
Transplantation, 21, 1137-9. <a
href="http://dx.doi.org/10.1093/ndt/gfi258">[Mo
re Information]</a>
Harris, D., Elder, G., Kairaitis, L., Rangan, G.
(2005). Basic Clinical Dialysis. Sydney:
McGraw-Hill, Medical Pub. Division.
Rangan, G., Pippin, J., Coombes, J., Couser, W.
(2005). C5b-9 does not mediate chronic
tubulointerstitial disease in the absence of
proteinuria. Kidney International, 67(2),
492-503. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15673297">[More Information]</a>
Tay, Y., Wang, Y., Kairaitis, L., Rangan, G.,
Zhang, C., Harris, D. (2005). Can murine
diabetic nephropathy be separated from
superimposed acute renal failure? Kidney
International, 68(1), 391-398. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15954931">[More Information]</a>
Rangan, G., Wang, Y., Tay, Y., Harris, D.
(2005). Differential effects of albumin on
cytokine gene expression in proximal tubular
epithelial cells. Nephrology, Dialysis,
Transplantation, 20(5), 1013-1014.
Rangan, G., Tay, Y., Harris, D. (2005).
Differential effects of albumin on cytokine gene
expression in proximal tubular epithelial cells.
Nephrology, Dialysis, Transplantation, 20(5),
1013-4. <a
href="http://dx.doi.org/10.1093/ndt/gfh733">[M
ore Information]</a>
Rangan, G., Wang, Y., Harris, D., Tay, Y.,
Coombes, J. (2005). Effect of nephrotoxins on
tubulointerstitial injury and NF-kappaB
activation in Adriamycin nephropathy. Renal
Publications for Gopala Rangan
Failure, 27(5), 609-14. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16153002">[More Information]</a>
Wang, Y., Mahajan, D., Tay, Y., Bao, B., Spicer,
T., Kairaitis, L., Rangan, G., Harris, D. (2005).
Partial depletion of macrophages by ED7 reduces
renal injury in Adriamycin nephropathy.
Nephrology, 10(5), 470-7. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16221097">[More Information]</a>
Liddle, C., Rangan, G., Coombes, J., Mreich, E.
(2005). Rapamycin worsens renal function and
intratubular cast formation in protein overload
nephropathy. Kidney International. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16316336">[More Information]</a>
Harris, D., Rangan, G. (2005). Retardation of
kidney failure -- applying principles to practice.
Annals of the Academy of Medicine, Singapore
(AAMS), 34(1), 16-23. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15726215">[More Information]</a>
2004
Rangan, G., Pippin, J., Couser, W. (2004).
C5B-9 Regulates Peritubular Myofibroblast
Accumulation In Experimental Focal Segmental
Glomerulosclerosis. Kidney International, 66(5),
1838-1848.
2003
Rangan, G., Harris, D. (2003). A blast from the
mast? Kidney International, 64(3), 1134-1135.